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Abstract
Sample size justification is an important consideration when planning a clinical trial, not only for the main
trial but also for any preliminary pilot trial. When the outcome is a continuous variable, the sample size
calculation requires an accurate estimate of the standard deviation of the outcome measure. A pilot trial
can be used to get an estimate of the standard deviation, which could then be used to anticipate what may
be observed in the main trial. However, an important consideration is that pilot trials often estimate the
standard deviation parameter imprecisely. This paper looks at how we can choose an external pilot trial
sample size in order to minimise the sample size of the overall clinical trial programme, that is, the pilot
and the main trial together. We produce a method of calculating the optimal solution to the required pilot
trial sample size when the standardised effect size for the main trial is known. However, as it may not be
possible to know the standardised effect size to be used prior to the pilot trial, approximate rules are also
presented. For a main trial designed with 90% power and two-sided 5% significance, we recommend pilot
trial sample sizes per treatment arm of 75, 25, 15 and 10 for standardised effect sizes that are extra small
(0.1), small (0.2), medium (0.5) or large (0.8), respectively.
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1 Introduction
Sample size is an important consideration when a clinical trial is planned, not only for the main trial
but also for any preliminary pilot trial. A sample size calculation is used to determine the minimum
number of participants needed in a clinical trial in order to be able to answer the research question
under investigation.1 Recruiting too few participants in a main trial means that the probability of
ﬁnding a clinically relevant diﬀerence statistically signiﬁcant is low and as a consequence, the chance
of inconclusive results is high.2,3 Conversely, if the sample size is too large, resources may be wasted,
more patients than necessary could be given a treatment which will later be proven to be inferior; or
an eﬀective treatment may be delayed from being released on to the market.4
For the purpose of this work, we are deﬁning a pilot randomised trial as a trial, which mimics the
design of the main trial but is not designed with the aim to prove the superiority of one treatment
over another5 but rather to try out aspects of the proposed main trial. As pilot trials do not have the
same objectives as a main trial, setting the sample size in the same way – using formal power
considerations – is usually not necessary. However, it is still necessary to provide a sample size
justiﬁcation even when the reasons for choosing a particular size are pragmatic.
The focus of this paper will be deriving pilot trial sample sizes based on a primary aim of the pilot
being to estimate the standard deviation to be used for the main trial sample size calculation. We will
describe a method for estimating the sample size for a pilot trial, which achieves the objective of
minimising the recruitment of patients across the pilot and the main trial overall. The emphasis in
this paper is on two armed superiority trials; however, the results are easily generalisable to trials
with other designs. Furthermore, we will concentrate on external pilot trials where the assumption,
however, is that there are no changes between it and the main trial, so that the standard deviation of
the outcome measurement is unaﬀected. We are also not considering the situation of an internal
pilot trial where the data are combined from the pilot trial and the main trial for the ﬁnal analysis.
2 Standard methods
For a continuous normally distributed outcome, in a superiority trial, the sample size per treatment
arm, n, to ensure adequate power (1–) where  is the Type II error rate whilst controlling the Type I
error rate, a, for a speciﬁed/required treatment diﬀerence, d, and standard deviation, s, is given by
n ¼ ðrþ 1Þðz1 þ z1=2Þ22
rd2
ð1Þ
where r is the allocation ratio of participants between the two treatment arms, experimental to
control.6
Subjective clinical expertise can be used to specify the required treatment diﬀerence and there are
agreed values used for the Type I and II error levels. However, a diﬃculty arises when trying to
quantify the standard deviation.7 Estimating the standard deviation at an inappropriate level can
have a serious eﬀect on the power of the study.8 If the anticipated standard deviation is estimated to
be too high, the trial will contain more participants than necessary. If the anticipated value is
estimated to be too low, the trial will not contain enough participants to ﬁnd the required eﬀect,
leading to the problems outlined in Section 1.
One of the methods investigators might use to try to get an accurate prediction of the true
standard deviation (or variance) of the outcome measure is to conduct an external pilot trial
prior to the main trial. Pilot trials are often small; therefore, they tend to imprecisely predict the
true variance. The anticipated distribution of the pilot variance is a chi-squared distribution.9 As a
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consequence, the accuracy of the variance prediction will depend on the pilot sample size and, hence,
the degrees of freedom for the variance. Estimating the main trial sample size from equation (1) can
result in a loss of power when the variance is imprecisely estimated. Using previous trial results to
estimate the variance introduces a type of imprecision that should be allowed for when estimating
the sample size for the main trial.9
2.1 Adjusting the standard deviation estimate from a pilot trial
Two diﬀerent methods have been developed to try to deal with the issue of imprecise variance
estimates. The ﬁrst was proposed by Browne10 and will be referred to as the upper conﬁdence
limit (UCL) approach and the second by Julious and Owen9 which will be referred to as the non-
central t-distribution (NCT) approach. In both methods, the sample size is inﬂated to allow for the
imprecision involved when estimating the variance of an outcome measure from a pilot trial.
2.1.1 UCL approach
The UCL approach uses an 100X%UCL for the estimated value of the variance from the pilot trial
to plan the main trial. Browne10 contended that this provides a sample size suﬃcient to achieve the
required power in at least 100X% of such trials. Browne recommends an 80% upper conﬁdence
level. However, Sim and Lewis,11 whose results will be discussed later in the paper, set X at 0.95 or
the 95% level.
In order to implement the UCL approach, a variance estimate from the pilot data is obtained and
the one-sided X% UCL for this variance, s2UCL, is calculated. A one-sided 100X% UCL for the
variance can be calculated from
s2UCL ¼
k
21X,k
" #
s2 ð2Þ
where s2 is the pooled variance from the pilot trial with k degrees of freedom for the variance
estimate, and 21X,k denotes the 1 X percentile of the chi-squared distribution with k degrees of
freedom.12 As k increases, the conﬁdence interval for a variance estimate becomes narrower.
Note for a two arm parallel group pilot trial with equal allocation to treatments, k would usually
be k ¼ 2m 2, where m is the sample size per arm in the pilot trial from which the variance is being
estimated.
This UCL would, therefore, be used as the variance estimate in the traditional sample size
equation given earlier in equation (1). Therefore, the sample size per treatment arm for the main
trial, nM, would be given by
nM ¼
rþ 1ð Þ z1 þ z1=2
 2
s2UCL
rd2
: ð3Þ
If we investigate how much larger the sample size estimate is from this approach compared to the
standard approach, by dividing equation (3) by equation (1) with s2 used as an estimate of 2, we
ﬁnd that the UCL approach sample size is larger by a factor of ½ k
2
1X,k
. Therefore, the factor by which
the UCL approach sample size is greater than the standard approach depends only upon the pilot
trial sample size and the value of X. It is possible, therefore, to calculate inﬂation factors, which can
be used to multiply by the sample size from a standard calculation to give the sample size for the
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UCL approach for a set value of total pilot trial sample size and X; these can be seen in Table 1.
The pilot trial sample sizes used here are total sample sizes across treatment arms – assuming for the
purpose of this paper, the trial is a two armed trial.
2.1.2 NCT approach
Julious and Owen9 suggest an alternative method for the calculation of sample size accounting for
the fact that we are using a sample estimate of the variance rather than the population variance in
the calculation. The sample size inﬂation is dependent on the number of degrees of freedom on
which the estimate of the variance is based, k; therefore, the sample size per treatment arm for the
main trial, nM, would be given by
nM 
ðrþ 1Þ t1 1 , k, t1 1 =2, nM rþ 1ð Þ  2, 0ð Þ
  2
s2
rd2
ð4Þ
where t1 :, k, að Þ is the inverse function of the cumulative distribution function of a NCT with a non-
centrality parameter, a, on k degrees of freedom. The non-centrality parameter in this case is
t1 1 =2, nM rþ 1ð Þ  2, 0ð Þ which is the inverse function of the cumulative distribution function
of a central t-distribution with nM rþ 1ð Þ  2 degrees of freedom (as a¼ 0). Here k is the degrees of
freedom for the variance estimate s2. If the estimate of the variance is based on only a few degrees of
freedom, the sample size will be increased. Consequently, as the number of degrees of freedom for the
estimate of the variance increases, the impact of this method on the sample size diminishes. As can be
seen in the paper by Julious and Owen,9 it is also possible to calculate inﬂation factors for the NCT
approach. The inﬂation factor represents how much larger the NCT approach sample size would be
compared to the standard sample size calculation. Table 2 shows the inﬂation factors for this approach
for total pilot trial sample sizes.
The UCL approach inﬂation depends only on the pilot trial sample size and the chosen level of X,
whereas the NCT inﬂation factor depends on the pilot trial sample size and the Type I and Type II
error rates. We can see from Tables 1 and 2 that the inﬂation factors for the UCL approach when X
is 80 or 95% are much higher than the inﬂation factors for the NCT approach. Table 3 demonstrates
which value of X in the UCL approach would make the inﬂation factor equal to that of the NCT
method, as well as the resulting inﬂation factor, the sample sizes presented are total pilot trial sample
sizes.
Table 1. Inflation factors for the sample size calculation using the UCL approach.
Pilot trial
sample size
80% upper
confidence limit
95% upper
confidence limit
20 1.400 1.917
24 1.349 1.783
30 1.297 1.654
40 1.244 1.527
50 1.211 1.450
70 1.172 1.359
100 1.139 1.287
200 1.093 1.190
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It can be seen that as the pilot sample size increases the value for X in the UCL approach, which
would lead to the same sample size as the NCT approach tends towards 0.5 and the inﬂation factor
tends towards 1.
2.2 Pilot trial sample sizes
So far, we have highlighted how to estimate the sample size for a main trial based on the estimates of
variance from a pilot trial. The question now being considered is how to estimate the sample size for
the pilot trial in the situation where the variance estimate from the pilot trial is being used to design a
main trial.
As highlighted previously, in a pilot trial the objective is not to prove superiority of the treatment
but to test trial procedures and processes and to get estimates of parameters for the main trial sample
Table 3. Inflation factors and levels of X for the UCL approach that give the same sample size as the
NCT approach.
Pilot trial sample size
Power
90% 80%
X Inflation factor X Inflation factor
20 0.622 1.156 0.566 1.099
24 0.611 1.125 0.560 1.080
30 0.599 1.097 0.553 1.062
40 0.586 1.071 0.546 1.045
50 0.577 1.056 0.541 1.036
70 0.565 1.039 0.534 1.025
100 0.554 1.027 0.529 1.017
200 0.538 1.013 0.520 1.008
Table 2. Inflation factors for the sample size calculation for the NCT
approach when the Type I error is 5%.
Pilot trial sample size
Power
90% 80%
20 1.156 1.099
24 1.125 1.080
30 1.097 1.062
40 1.071 1.045
50 1.055 1.036
70 1.039 1.025
100 1.027 1.017
200 1.013 1.009
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size calculation.13–15 Therefore, the sample size formulae which are used for main treatment
assessments are not usually applicable to pilot trials. The Consolidated Standards of Reporting
Trials Group and bodies such as The National Institute for Health Research and The National
Research Ethics Service state that not all studies necessarily need a power-based sample size
calculation but they do all need a sample size justiﬁcation. Therefore, since the purpose of the
pilot is not to give a formal assessment of eﬃcacy, then the sample size provided by the
conventional calculations may be higher than necessary.13
2.2.1 Rules of thumb
When estimating the sample size for the pilot trial, the simplest methods to apply are sample size
rules of thumb. Browne10 cites a general ﬂat rule to ‘use at least 30 subjects or greater to estimate a
parameter’, whereas Julious16 suggests a minimum sample size of 12 subjects per treatment arm.
Teare et al.17 recommend a pilot trial sample size of 70 in order to reduce the imprecision around the
estimate of the standard deviation. All of these rules have limitations, however, as they are
applied regardless of the size of the main trial being designed. The cost of the simplicity of this
ﬂat approach, is a larger overall sample size when the main trial is large or small, as demonstrated in
Section 4.
2.2.2 Minimising the sample size across studies approach
If one of the adjustment methods described in the previous section to account for imprecision in the
variance estimation is applied to calculate the main trial sample size, it would mean that the pilot
trial sample size would aﬀect the sample size of the main trial. That is, the methods depend on the
degrees of freedom around the variance estimate and hence the pilot sample size.
There is a trade-oﬀ, therefore, between having a small pilot study and a larger main trial or a
larger pilot study and a smaller main trial. This is because the larger the pilot the more precisely
estimated the variance will be and, hence, the smaller the inﬂation factor applied to the main study
sample size calculation. However, eventually the pilot sample size will get too large, and the number
included in the pilot trial will outweigh the reduction in the main trial sample size. Therefore, it may
be appropriate to consider the implications of this relationship when choosing the sample size of the
pilot trial.
The method of setting the pilot trial sample size in order to minimise the overall sample size of the
pilot and the main trial together was described by Kieser and Wassmer.12 They applied the 80%
UCL approach to the sample size calculation and found that a pilot trial sample size between 20 and
40 would minimise the overall sample size for a main study sample size of 80–250 corresponding to
standardised eﬀect sizes of 0.4 and 0.7 (for 90% power based on a standard sample size calculation).
Sim and Lewis11 also applied the UCL approach in their work but with a 95% UCL. They found
that a pilot trial of n 55 would minimise the overall sample size for small to medium standardised
eﬀect sizes (0.2–0.6). The impact of Sim and Lewis’ use of a 95% UCL is that it has the eﬀect of
increasing their estimate of the required sample size compared to Kieser and Wassmer, for both the
pilot and the main trial.
The current methods for setting pilot trial sample sizes are based on a set of rules, which we will
call ﬂat rules of thumb, these are given in Table 4. These pilot sample sizes are ﬁxed no matter how
large the subsequent main trial will be.
Please note that the sample sizes presented in Tables 1 to 4 and in Figures 2 to 4 are the total
sample size required for a two arm trial. This has been done to allow for comparisons to be made
between the ﬂat rules of thumb: as some rules are based on the numbers of participants required per
arm and some are based on the total number of participants required – for example, Sim and Lewis11
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recommend 55 or more patients in total. The results presented in Figure 1 and Tables 5, 6 and 8 are
per treatment arm. This allows for generalisability to trials with two or more treatment arms.
2.3 Summary of standard methods
Setting the pilot trial sample size in order to minimise the total sample size of the pilot and the main
trial together could be argued to be the most appropriate method of sample size calculation as it
recognises that the pilot trial is part of a larger clinical development programme, rather than a stand-
alone study. Other methods fail to recognise this point and aim to minimise both the pilot and the
main trials separately which could lead to the suboptimal sample size overall.
3 Proposed methods of optimising the sample size across studies
Using standardised diﬀerences ( ¼ d=s) and pilot trial sample sizes per treatment group of 1 and
upwards, we can calculate the required main trial sample sizes based on all combinations of these
variables using the NCT approach through equation (4). As nM appears on both sides of equation
(4), it can be solved iteratively. To calculate a starting point for the iterations we can use,
nSTART ¼
rþ 1ð Þs2 t1 1 , k, z1=2
  2
rd2
ð5Þ
which gives a direct estimate of the sample size without iteration. Once the required main trial
sample size per arm, nM, has been found, it is then added to the speciﬁed pilot trial sample size
per arm, m, m ¼ ðkþ 2)/2 for a two armed design, to ﬁnd the overall study sample size per arm (NO)
if this design is to be used.
NO ¼ mþ nM ð6Þ
For each value of , the pilot trial sample size per arm, mOPT, which minimises the size of the overall
study, NO, can be found; this is referred to as the optimal pilot trial sample size. Therefore, if the  to
be used in the main trial is known, it is possible to calculate exactly the optimal pilot trial sample size
in order to minimise the overall trial sample size. This process is depicted in Figure 1.
However, the exact  to be used in the main trial may not be known at this early stage. Therefore,
pilot trial sample size rules of thumb have been calculated based on the small, medium or large
standardised eﬀect sizes as set out by Cohen.18
Table 4. The current flat rules of thumb for overall pilot trial sample size of
a two armed trial.
Author
Recommended pilot
trial sample size
Julious16 24
Kieser and Wassmer12 20–40
Browne10 30
Sim and Lewis11 55
Teare et al.17 70
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Figure 1. Process for calculating the optimal pilot trial sample size.
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4 Results
4.1 Optimal sample sizes
In order to calculate the minimum possible overall sample size for each standardised diﬀerence and
adjustment method, the method presented in Figure 1 was used. The total sample size required for a
two armed main trial for standardised diﬀerences of 0.2, 0.5 and 0.8 can be seen in Figures 2 to 4,
these were calculated based on a power of 90%, Type I error rate of 5% and an allocation ratio, r,
of 1.
It can be seen from Figures 2 to 4 that it is possible to solve the function and ﬁnd the pilot trial
sample size, which minimises the overall trial sample size. Table 2 shows the optimal pilot sample
size, the required main trial sample size for the pilot trial and then the resulting overall trial sample
Table 5. Theoretical optimal values of pilot trial, main trial and overall trial sample size per treatment arm for each
inflation method.
Inflation method
Standardised
difference
80% upper confidence limit 95% upper confidence limit Non-central t-distribution
Pilot Main Overall Pilot Main Overall Pilot Main Overall
80% powered main trial
0.05 210 6671 6881 331 6892 7223 74 6353 6427
0.10 88 1728 1816 139 1817 1956 38 1607 1645
0.20 39 457 496 61 493 554 20 412 432
0.25 30 300 330 47 326 373 16 267 283
0.30 24 213 237 38 234 272 14 188 202
0.40 18 125 143 28 139 167 11 108 119
0.50 14 83 97 22 94 116 9 71 80
0.60 12 60 72 18 69 87 8 51 59
0.70 10 45 55 16 53 69 7 38 45
0.75 10 40 50 15 47 62 7 33 40
0.80 9 36 45 14 42 56 6 30 36
0.90 8 29 37 13 35 48 6 24 30
1.00 7 25 32 11 29 40 5 20 25
90% powered main trial
0.05 253 8880 9133 398 9149 9547 106 8511 8617
0.10 106 2292 2398 167 2400 2567 54 2154 2208
0.20 46 603 649 72 647 719 28 552 580
0.25 35 394 429 56 427 483 23 358 381
0.30 29 279 308 45 305 350 19 252 271
0.40 21 163 184 33 181 214 15 145 160
0.50 16 108 124 26 122 148 12 95 107
0.60 14 78 92 21 89 110 11 68 79
0.70 12 59 71 18 68 86 9 51 60
0.75 11 52 63 17 60 77 9 45 54
0.80 10 46 56 16 54 70 8 40 48
0.90 9 38 47 14 44 58 8 32 40
1.00 8 32 40 13 37 50 7 27 34
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size per treatment group for all adjustment methods based on a main trial power of 80%. Table 2
shows the same results but for a main trial power of 90%. The sample sizes presented in the tables
are per treatment group.
The straight line on the graphs depicts a standard sample size calculation with no adjustment
method applied (based on equation (1)). The points on the line show the resulting overall sample size
if the rules of thumb of 24, 30 or 70 were used with no adjustment applied, the population variance is
assumed to be known. The bottom dashed curve represents the NCT method as proposed by Julious
and Owen.9 The points on the line show the resulting overall trial sample size if the rules of thumb of
24 or 30 subjects were used for the pilot trial. The middle curve is the UCL method with an 80%
UCL for the variance. The points represent the rules of thumb of 20 and 40 as set out by Kieser and
Table 6. Theoretical optimal values of pilot trial, main trial and overall trial sample size per treatment arm for each
inflation method with a floor on the lower limit of pilot trial sample size at 10 per arm.
Inflation method
Standardised
difference
80% upper confidence limit 95% upper confidence limit Non-central t-distribution
Pilot Main Overall Pilot Main Overall Pilot Main Overall
80% powered main trial
0.05 210 6671 6881 331 6892 7223 74 6353 6427
0.10 88 1728 1816 139 1817 1956 38 1607 1645
0.20 39 457 496 61 493 554 20 412 432
0.25 30 300 330 47 326 373 16 267 283
0.30 24 213 237 38 234 272 14 188 202
0.40 18 125 143 28 139 167 11 108 119
0.50 14 83 97 22 94 116 10 70 80
0.60 12 60 72 18 69 87 10 49 59
0.70 10 45 55 16 53 69 10 36 46
0.75 10 40 50 15 47 62 10 31 41
0.80 10 35 45 14 42 56 10 28 38
0.90 10 28 38 13 35 48 10 22 32
1.00 10 22 32 11 29 40 10 18 28
90% powered main trial
0.05 253 8880 9133 398 9149 9547 106 8511 8617
0.10 106 2292 2398 167 2400 2567 54 2154 2208
0.20 46 603 649 72 647 719 28 552 580
0.25 35 394 429 56 427 483 23 358 381
0.30 29 279 308 45 305 350 19 252 271
0.40 21 163 184 33 181 214 15 145 160
0.50 16 108 124 26 122 148 12 95 107
0.60 14 78 92 21 89 110 11 68 79
0.70 12 59 71 18 68 86 10 50 60
0.75 11 52 63 17 60 77 10 44 54
0.80 10 46 56 16 54 70 10 39 49
0.90 10 37 47 14 44 58 10 31 41
1.00 10 30 40 13 37 50 10 25 35
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Wassmer12 as well as the 24 and 30 rules. The top dotted curve is the UCL method with a 95% UCL
for the variance. The point for a pilot trial sample size of 55 has been added here, as this was the
sample size recommended by Sim and Lewis11 to minimise the overall trial sample size. The overall
trial sample sizes on the graphs are the total for a two armed trial.
The graphs in Figures 2 to 4 can be used to compare the eﬀects of using the rules of thumb
described in Table 2 to the theoretical optimal solution. For a medium standardised eﬀect size (e.g.,
0.5), the suggested rules of thumb are very close to the optimal pilot sample size. However, when the
standardised eﬀect size moves away from this value, the rules of thumb are less useful. For small
standardised eﬀect sizes (e.g., 0.2), the rules of thumb underestimate the required size of the pilot
trial. For large standardised eﬀect sizes (e.g., 0.8), the rules of thumb overestimate the number of
participants required for the pilot trial. This indicates that the larger the main trial the larger the
pilot trial should be in order to minimise the overall sample size; therefore; one ﬁxed ﬂat pilot trial
sample size will not be suitable for all studies.
In relation to overall trial sample size, overestimating the pilot sample size is not as costly as
underestimation in terms of over recruitment of participants as shown in Figures 2 to 4, given that
Figure 2. Comparing overall total trial sample sizes for each adjustment method over varying pilot trial sample size
for a standardised difference of 0.2.
*Lines from bottom to top: Line 1, Standard sample size calculation with no adjustment method applied (points
represent pilot trial sample sizes of 24, 30 and 70); Line 2, Main trial sample size calculation based on the NCT
approach (points represent pilot trial sample sizes of 24 and 30); Line 3, Main trial sample size calculation based on the
80% UCL approach (points represent pilot trial sample sizes of 20, 24, 30 and 40) and Line 4, Main trial sample size
calculation based on the 95% UCL approach (point represents pilot trial sample size of 55).
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the slope on the right hand side is ﬂatter than on the left. The gradient of the slope on the right hand
side of the minimum value is less than the gradient of the slope to the left side of the minimum;
therefore, for the same change in pilot trial sample size – over estimation compared to underestimation
– the change in overall trial sample size will be comparatively less. It can be seen that the NCT
approach produces consistently lower overall trial sample sizes than any of the UCL methods.
It should be noted that for large values of standardised eﬀect size, the suggested pilot trial sample
size falls to a level, which may be considered too low to achieve the objectives of a pilot trial. This is
because pilot trials are not only used to estimate the standard deviation of the outcome measure but
also to assess objectives such as testing the feasibility of trial processes or predicting the likely
dropout rate. We must consider these other objectives as well as more practical considerations.
For the rest of this paper, a ﬂoor will be placed on the minimum pilot trial sample size per arm
of 10 participants; this allows some investigation of these other objectives and is in line with the
minimum sample size for an internal pilot trial sample size as recommended by Birkett and Day.19
Figure 3. Comparing overall trial sample sizes for each adjustment method for varying pilot trial sample sizes for a
standardised difference of 0.5.
*Lines from bottom to top: Line 1, Standard sample size calculation with no adjustment method applied (points
represent pilot trial sample sizes of 24, 30 and 70); Line 2, Main trial sample size calculation based on the NCT
approach (points represent pilot trial sample sizes of 24 and 30); Line 3, Main trial sample size calculation based on the
80% UCL approach (points represent pilot trial sample sizes of 20, 24, 30 and 40) and Line 4, Main trial sample size
calculation based on the 95% UCL approach (point represents pilot trial sample size of 55).
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Table 6 (80% powered main trial and 90% powered main trial) represents the optimal results with a
ﬂoor on the lower limit of the pilot study sample size at 10 per treatment group.
It should also be noted that although the exact calculation for the NCT approach (equation 4)
has been used here to gain the most accurate results, in practice using the approximation in equation
5 will result in an overall study sample size of one subject less than the exact calculation at the most.
Table 6 shows again that the NCT method produces smaller overall trial sample sizes than both
the 80% and 95% UCL methods. There is, on average, no loss of power when using the NCT
approach, simulations and the results can be seen in Table 7. In order to calculate the results in
Table 7, a pilot trial was simulated with two treatment arms. The results were drawn from a normal
distribution, the control arm with a mean of 0 and a variance of 1 and the experimental arm with a
mean of the required eﬀect size and variance of 1. Depending on the adjustment method we were
looking at, the pilot trial was set to the optimal sample size for that approach and eﬀect size. The
standard deviation was estimated from the pilot trial, this was then used to calculate the sample size
Figure 4. Comparing overall trial sample sizes for each adjustment method for varying pilot trial sample sizes for a
standardised difference of 0.8.
*Lines from bottom to top: Line 1, Standard sample size calculation with no adjustment method applied (points
represent pilot trial sample sizes of 24, 30 and 70); Line 2, Main trial sample size calculation based on the NCT
approach (points represent pilot trial sample sizes of 24 and 30); Line 3, Main trial sample size calculation based on the
80% UCL approach (points represent pilot trial sample sizes of 20, 24, 30 and 40) and Line 4, Main trial sample size
calculation based on the 95% UCL approach (point represents pilot trial sample size of 55).
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for the main trial (the method depending on the approach under investigation). The main trial
sample size calculations were based on a Type I error rate of 5%, a Type II error rate of 10%
and an allocation ratio between the treatment groups of 1. Using the same method as with the pilot
trial, the main trial was then simulated based on this sample size. The results of the main trial were
then tested using a t-test. This simulation was repeated 10,000 times for each situation. The analysis
was carried out in R 3.1.2.
From the simulations, the NCT approach gives the simulated average power closest to the
nominal power level. When the standardised eﬀect size is large, the 95% UCL approach has an
average power approximately 7% above the nominal value.
4.2 Rules of thumb revisited
In many trials, the actual value of standardised eﬀect size to be used in the main trial may not be
known before the pilot trial planning stage. This is one of the reasons that the existing rules of
thumb for the pilot trial sample size, as introduced earlier in the paper, are so attractive. However,
an investigator is likely to know whether the standardised diﬀerence for use in the main trial is likely
to be small, medium or large within a range.
From the results presented, it would seem that any rules of thumb should be stepped – and not
ﬂat – so that the pilot is bigger for smaller standardised eﬀect sizes and smaller for large standardised
eﬀect sizes.
Table 7. Average power for two armed trials designed using different adjustment methods based on 10,000
simulations using 90% power, 5% Type I error rate and ‘optimal’ pilot trial sample sizes.
Standardised
effect size
80% upper
confidence limit
95% upper
confidence limit
Non-central
t-distribution
0.05 Pilot trial sample size 506 796 212
Average power 91.25 92.51 90.52
Percentage of trials with power above 90% 81.71 95.19 57.91
Percentage of trials with power above 80% 100.00 100.00 99.87
0.1 Pilot trial sample size 212 334 108
Average power 92.12 93.21 90.34
Percentage of trials with power above 90% 82.15 95.93 60.34
Percentage of trials with power above 80% 99.98 100.00 99.00
0.2 Pilot trial sample size 92 144 56
Average power 93.17 94.75 90.36
Percentage of trials with power above 90% 83.12 95.87 64.2
Percentage of trials with power above 80% 99.74 100.00 96.15
0.5 Pilot trial sample size 32 52 24
Average power 94.37 96.66 92.09
Percentage of trials with power above 90% 84.19 95.60 68.90
Percentage of trials with power above 80% 97.89 99.86 91.00
0.8 Pilot trial sample size 20 32 20
Average power 95.37 97.60 92.10
Percentage of trials with power above 90% 84.73 95.85 69.45
Percentage of trials with power above 80% 95.33 99.53 89.23
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Table 6 (80% powered main trial and 90% powered main trial) has been used to derive new
stepped rules of thumb for the pilot trial sample size; these are presented in Table 8. These oﬀer (per
arm) sample sizes for pilot trials, which vary depending on whether the standardised eﬀect size for
the main trial is small, medium or large. An additional category of extra small has been inserted into
Cohen’s classiﬁcations, which represents standardised eﬀect sizes of 0.1 or less; this is because the
results for these trials were many times larger than for standardised eﬀect sizes of 0.2.
5 A worked example
A two armed parallel group randomised controlled clinical trial is being planned with a two-sided
Type I error rate of 5% and a power of 90%. The primary outcome is anticipated to take a normal
form. As the investigator initially was unsure about design aspects of the main trial such as the
anticipated standard deviation of the outcome measure and the likely recruitment and dropout rates,
a pilot trial was undertaken.
Initially a ﬂat rule of thumb was used, and the pilot sample size was chosen to be 24 evaluable
patients in total as recommended by Julious.16
However, suppose that a priori the standardised eﬀect size for the main trial is 0.25. Using the
NCT approach, the main trial sample size is estimated to be 760 participants, assuming that the pilot
trial of 24 was used to design the trial. This would result in a total sample size for the pilot and main
trial together of 784 participants.
As highlighted previously, if the standardised eﬀect size to be used in the main trial is known to be
0.25 prior to the pilot trial, then based on the method presented in this paper, the optimal pilot trial
sample size for a standardised diﬀerence of 0.25 is 46. If a pilot trial of 46 participants was carried
out and the main trial planned based on the estimate of the standard deviation from that pilot study;
then the main trial sample size based on the NCT approach would be 716. This method would result
in a total overall sample size of 762 participants.
Thus, by increasing the sample size for the pilot trial, in this example nearly doubling the sample
size, we have increased the precision around the standard deviation estimate. This has had the eﬀect
of reducing the total trial sample size by 22.
There are many instances where the eﬀect size for the main trial is unlikely to be known prior to
the pilot trial. However, it could be considered reasonable to have an approximate idea of the
sample size of the main trial based on experience of the same population, i.e. it is anticipated that
the eﬀect size will be quite small and the sample size large. Using the stepped rules of thumb (from
Table 8), the sample size would be set at 50 for the pilot trial. Consequently, the main trial sample
size calculation based on a standardised eﬀect size of 0.25 would be for 712 subjects; giving a total
overall trial sample size of 762. In this example due to rounding, the total sample size is the same for
the stepped rules of thumb approach and the optimal solution.
Table 8. Estimated stepped rules of thumb for required pilot trial sample size per
treatment arm when the NCTapproach will be used to calculate the main trial sample size.
Standardised difference 80% powered main trial 90% powered main trial
Extra small (< 0.1) 50 75
Small (0.1 < 0.3) 20 25
Medium (0.3 < 0.7) 10 15
Large ( 0.7) 10 10
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6 Discussion
The National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre
deﬁnes pilot trials in context of the planning of a future trial.20 Therefore, the method of
minimising the sample size across trials could be thought to be the most appropriate as it
treats the pilot trial as part of the whole study programme rather than a stand-alone trial. In
this paper, we propose a method for estimating the sample size for a pilot trial, which uses this
idea. The method introduced describes how to set the sample size of a pilot trial in order to
minimise the overall trial sample size, i.e. the sample size of the pilot and main trial together,
for diﬀerent correction methods.
We demonstrate how the size of the pilot trial impacts on the size of the overall trial when either
the UCL approach or the NCT method is used to calculate the sample size for the main trial. If the
pilot trial is large, the main trial will be relatively small and if the pilot trial is small, the main trial
will be relatively large. It can be seen from the results in this paper that the NCT approach provides
lower overall trial sample sizes than any other method while maintaining the average power at the
nominal level.
Our results show that as the sample size of a main trial increases, the size of the pilot trial should
also increase. For medium eﬀect sizes, the existing rules seem suﬃcient; however, as we move away
from a standardised eﬀect size of 0.5, the ﬂat rules of thumb can over or under estimate the pilot trial
sample size that would minimise the overall trial sample size. Therefore, using these ﬂat rules of
thumb would lead to more patients than theoretically required being recruited to the overall trial.
This is especially seen at small standardised eﬀect sizes.
From the results presented in this paper, we recommend using the NCT approach to set the main
trial sample size in conjunction with the method presented of calculating a pilot trial sample size.
Doing so will on average maintain the nominal power requirement and minimise the overall trial
sample size for the pilot and the main trial together.
If simpler calculations are to be undertaken for a pilot trial sample size, we recommend using the
stepped rules of thumb presented in the paper to set the pilot study sample size. However, if the
standardised eﬀect size to be used in the main trial is known, we recommend that the exact
calculation be used.
In the paper, the emphasis is on estimating the sample size for pilot trials to minimize the
overall sample size across both the main and pilot trial combined. However, there could be
other sample size considerations such as obtaining plausible estimates of the clinical eﬀect
through precision of the conﬁdence intervals.21–25 Alternatively, decision science criteria could
be used to optimize the risk discharged in a clinical development prior to the start of a late
phase study.26 In both these instances, a pilot trial is still considered in context with later
deﬁnitive trials but there may already – from previous work – be good estimates of the
population variance.
Finally, the methods described in the paper do have limitations. The main assumption is that
the design of the main trial and the pilot trial is ostensibly the same. This may not be the case,
however, which could impact on the applicability of the estimate of the standard deviation from the
pilot trial.
The methods described in the paper provide a way to estimate the optimal pilot trial sample size
that minimises the overall sample size for a given main trial standardised eﬀect size. We recognise
that the situation of knowing the eﬀect size prior to the pilot study is an ideal situation and so we
recommend that the stepped rules of thumb, proposed in this paper, be used and the ﬂat rules of
thumb only used as a last resort.
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